BioSpace News Archive

BioMidwest

Pelican BioThermal Releases an Update to its SaaS Asset Management Software, Crēdo ProEnvision™

New version advances smart management of temperature-controlled shipments and sets the foundation for future IoT integration

January 9, 2020
·
4 min read
Predicine and Merck KGaA, Darmstadt, Germany to Present Data at AACR – Advances in Liquid Biopsy Conference 2020

Predicine and Merck KGaA, Darmstadt, Germany collaboratively highlight the importance of multi-parametric profiling of ctDNA and cfRNA for holistic molecular insight for detecting driver mutation, monitoring disease burden and drug resistance in advanced stage colorectal cancer.

January 9, 2020
·
2 min read
FDA

Merck’s Keytruda Approved for High-Risk Bladder Cancer

Merck’s checkpoint inhibitor Keytruda (pembrolizumab) continues moving toward the projections of becoming the world’s best-selling drug.

January 9, 2020
·
3 min read
·
Mark Terry
Drug Development

Long-Term Data Bolsters DBV Technologies’ BLA for Viaskin Peanut

DBV announced positive topline results from its Phase III PEPITES trial evaluating the long-term efficacy and safety of investigational Viaskin Peanut in peanut-allergic children aged 4 to 11 years.

January 9, 2020
·
2 min read
·
Alex Keown
Business

Boehringer Ingelheim and Enleofen Ink $1 Billion+ Fibrosis Deal

In the deal, Boehringer acquired worldwide exclusive rights to Enleofen’s preclinical interleukein-11 (IL-11) platform.

January 9, 2020
·
3 min read
·
Mark Terry
Business

Pfizer and eFFECTOR Ink $507 Million Cancer Deal

Pfizer and Effector Therapeutics inked a global license and collaboration deal to develop small-molecule inhibitors of eukaryotic initiation factor 4E, also known as eIF4E.

January 9, 2020
·
3 min read
·
Mark Terry
Red Flags and Green Lights: How Employers View You

This article looks at job seeker traits that experts and employers characterize as red flags and offers suggestions to mitigate those obstacles.

January 9, 2020
·
4 min read
·
Katharine Hansen, PhD
PharmaMar in San Francisco during the J.P. Morgan Annual Healthcare Conference in San Francisco

Madrid, January 9th, 2020- PharmaMar management will be meeting with institutional investors in San Francisco during the JP Morgan Annual Healthcare Conference next week.

January 9, 2020
·
2 min read
Drug Development

MR Solutions grows its support network as it continues to expand sales of preclinical scanners

MR Solutions is continuing to expand its support network as its base of preclinical liquid helium free multimodality MRI systems become the norm in research laboratories across the world.

January 9, 2020
·
1 min read
Sebia enters into agreement with Sanofi to develop multiple myeloma diagnostic test

Test will specifically adjust for isatuximab-induced interference in complete response assessment of multiple myeloma patients

January 9, 2020
·
3 min read